The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

TRAF4  -  TNF receptor-associated factor 4

Homo sapiens

Synonyms: CART1, Cysteine-rich domain associated with RING and Traf domains protein 1, MLN 62, MLN62, Metastatic lymph node gene 62 protein, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of TRAF4

 

High impact information on TRAF4

  • TRAF4 directly associated with the focal contact scaffold Hic-5, and the knockdown of either protein, disruption of the complex, or oxidant scavenging blocked cell migration [6].
  • We found that the nicotinamide adenine dinucleotide phosphate reduced (NADPH) oxidase adaptor p47(phox) and its binding partner TRAF4 were sequestered within nascent, focal complexlike structures in the lamellae of motile endothelial cells [6].
  • Our data suggest that TRAF4 specifies a molecular address within focal complexes that is targeted for oxidative modification during cell migration [6].
  • Altogether, our results demonstrate that TRAF4 is required during embryogenesis in key biological processes including the formation of the trachea, the development of the axial skeleton, and the closure of the neural tube [7].
  • Overexpression of proapoptotic proteins caspase-9 and TRAF4 was seen in endothelial cells and smooth muscle cells from unstable hemorrhagic and ulcerated plaque regions [8].
 

Biological context of TRAF4

  • Furthermore, overexpression of TRAF4 abrogated the ability of dimerization to prevent the induction of apoptosis normally mediated by monomeric p75(NTR) [9].
  • In addition to its role in p70S6K activation, we postulate an anti-apoptotic role for TRAF4, because the agonistic anti-Fas antibody CH-11 induced apoptosis in untransfected HEK-293 cells, but not in TRAF4-expressing HEK-293 cells [10].
  • TRAF4 localizes to the cytoplasm and appears to remain in the cytoplasm following DNA damage [11].
  • These data suggest that activation of the NF-kappaB pathway is involved in up-regulation of TRAF4 in T-cells [12].
  • While TRAF4-GFP (T4-GFP) was clearly localized in the cytoplasm, the N-terminal deletion mutant, T4(259-470), comprising the TRAF domain of the molecule, and a C-terminal deletion mutant consisting mainly of the RING and zinc finger domains of TRAF4 were both localized predominantly to the nucleus [12].
 

Anatomical context of TRAF4

  • A secondary screen of endothelial cell proteins for TRAF4-interacting partners yielded a number of proteins known to control cell fate [13].
  • In addition, TRAF4, like p47(phox), was recovered largely in the cytoskeleton/membrane fraction [13].
  • All three HD cell lines showed strong expression of TRAF2 protein and moderate, comparatively equal expression of TRAF4 and TRAF6 [14].
  • Here, we show that endogenous TRAF4 and MEKK4 associate in both human K562 cells and mouse E10.5 embryos [15].
  • These results suggest that TRAF4 participates in the molecular mechanism underlying silencing of TLR-mediated signaling through the interaction with molecules harboring phagosome/endosome membrane [16].
 

Associations of TRAF4 with chemical compounds

  • The murine TRAF4 promoter contains a functional p53 DNA-binding site approximately 1 kilobase upstream of the initiating methionine [11].
  • Tumor necrosis factor receptor associated factor 4 (TRAF4) expression pattern during mouse development [17].
  • To validate two new commercial instruments, (Siemens-Elema Servo Ventilator 900B, Beckman Metabolic Cart), the authors constructed a lung model into which they delivered CO2 and N2 at precise rates to simulate Co2 production (Vco2) and O2 consumption (Vos) [18].
  • On-line oxygen consumption VO2 measurements were obtained throughout using the Beckman Horizon Metabolic Cart [19].
  • The nonintervened reference coronary segments of the PCI vessel demonstrated improvements with AGI-1067 in the Canadian Antioxidant Restenosis Trial-1 (CART-1), evidence supportive of a clinical effect on slowing atherosclerosis progression [20].
 

Physical interactions of TRAF4

 

Regulatory relationships of TRAF4

  • Despite intensive research, the function of TRAF4 in signaling pathways triggered by TNFR-related proteins remains enigmatic [21].
 

Other interactions of TRAF4

 

Analytical, diagnostic and therapeutic context of TRAF4

References

  1. TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues. Krajewska, M., Krajewski, S., Zapata, J.M., Van Arsdale, T., Gascoyne, R.D., Berern, K., McFadden, D., Shabaik, A., Hugh, J., Reynolds, A., Clevenger, C.V., Reed, J.C. Am. J. Pathol. (1998) [Pubmed]
  2. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. Régnier, C.H., Tomasetto, C., Moog-Lutz, C., Chenard, M.P., Wendling, C., Basset, P., Rio, M.C. J. Biol. Chem. (1995) [Pubmed]
  3. Re: Pavelka K, Gatterova J, Gallerova V, Urbanova Z, Sedlackova M, Altman R. A 5-year randomized controlled double-bling study of glycosaminoglycan polysulfuric acid complex (Rumalon) as a structure-modifying therapy in osteoarthritis of the hip and knee. Oseoarthritis Cart 2000;8:335-342. Lequesne, M. Osteoarthr. Cartil. (2001) [Pubmed]
  4. Assessment of oxygen-consumption by use of reverse Fick-principle and indirect calorimetry in critically Ill patients. Schneeweiss, B., Druml, W., Graninger, W., Grimm, G., Kleinberger, G., Lenz, K., Laggner, A. Clinical nutrition (Edinburgh, Scotland) (1989) [Pubmed]
  5. TRAF4 overexpression is a common characteristic of human carcinomas. Camilleri-Broët, S., Cremer, I., Marmey, B., Comperat, E., Viguié, F., Audouin, J., Rio, M.C., Fridman, W.H., Sautès-Fridman, C., Régnier, C.H. Oncogene (2007) [Pubmed]
  6. Subcellular targeting of oxidants during endothelial cell migration. Wu, R.F., Xu, Y.C., Ma, Z., Nwariaku, F.E., Sarosi, G.A., Terada, L.S. J. Cell Biol. (2005) [Pubmed]
  7. Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. Régnier, C.H., Masson, R., Kedinger, V., Textoris, J., Stoll, I., Chenard, M.P., Dierich, A., Tomasetto, C., Rio, M.C. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  8. Identification of differential protein expression associated with development of unstable human carotid plaques. Slevin, M., Elasbali, A.B., Miguel Turu, M., Krupinski, J., Badimon, L., Gaffney, J. Am. J. Pathol. (2006) [Pubmed]
  9. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. Ye, X., Mehlen, P., Rabizadeh, S., VanArsdale, T., Zhang, H., Shin, H., Wang, J.J., Leo, E., Zapata, J., Hauser, C.A., Reed, J.C., Bredesen, D.E. J. Biol. Chem. (1999) [Pubmed]
  10. Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinase. Fleckenstein, D.S., Dirks, W.G., Drexler, H.G., Quentmeier, H. Leuk. Res. (2003) [Pubmed]
  11. Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene. Sax, J.K., El-Deiry, W.S. J. Biol. Chem. (2003) [Pubmed]
  12. Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4). Glauner, H., Siegmund, D., Motejadded, H., Scheurich, P., Henkler, F., Janssen, O., Wajant, H. Eur. J. Biochem. (2002) [Pubmed]
  13. Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase. Xu, Y.C., Wu, R.F., Gu, Y., Yang, Y.S., Yang, M.C., Nwariaku, F.E., Terada, L.S. J. Biol. Chem. (2002) [Pubmed]
  14. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells. Izban, K.F., Ergin, M., Martinez, R.L., Alkan, S. Mod. Pathol. (2000) [Pubmed]
  15. MEKK4 is an effector of the embryonic TRAF4 for JNK activation. Abell, A.N., Johnson, G.L. J. Biol. Chem. (2005) [Pubmed]
  16. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. Takeshita, F., Ishii, K.J., Kobiyama, K., Kojima, Y., Coban, C., Sasaki, S., Ishii, N., Klinman, D.M., Okuda, K., Akira, S., Suzuki, K. Eur. J. Immunol. (2005) [Pubmed]
  17. Tumor necrosis factor receptor associated factor 4 (TRAF4) expression pattern during mouse development. Masson, R., Régnier, C.H., Chenard, M.P., Wendling, C., Mattei, M.G., Tomasetto, C., Rio, M.C. Mech. Dev. (1998) [Pubmed]
  18. A systematic method for validation of gas exchange measurements. Damask, M.C., Weissman, C., Askanazi, J., Hyman, A.I., Rosenbaum, S.H., Kinney, J.M. Anesthesiology (1982) [Pubmed]
  19. Role of mechanical power estimates in the O2 cost of walking in children with cerebral palsy. Unnithan, V.B., Dowling, J.J., Frost, G., Bar-Or, O. Medicine and science in sports and exercise. (1999) [Pubmed]
  20. Antioxidants: The good, the bad and the ugly. Tardif, J. The Canadian journal of cardiology. (2006) [Pubmed]
  21. TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation. Esparza, E.M., Arch, R.H. Cell. Mol. Life Sci. (2004) [Pubmed]
  22. Selective recognition of peptide sequences by glutathione transferases: a possible mechanism for modulation of cellular stress-induced signaling pathways. Edalat, M., Persson, M.A., Mannervik, B. Biol. Chem. (2003) [Pubmed]
  23. The accuracy of the TriTrac-R3D accelerometer to estimate energy expenditure. Jakicic, J.M., Winters, C., Lagally, K., Ho, J., Robertson, R.J., Wing, R.R. Medicine and science in sports and exercise. (1999) [Pubmed]
  24. Association of conventional and exertional coronary heart disease risk factors in 5,000 apparently healthy men. Davies, B., Ashton, W.D., Rowlands, D.J., eL-Sayed, M., Wallace, P.C., Duckett, K., Coley, J., Daggett, A.M. Clinical cardiology. (1996) [Pubmed]
  25. SCID repopulating cells derived from unmobilised adult human peripheral blood. Abuljadayel, I.S., Afghan, R.K., McCaffrey, T.A., Lundergan, C., Hawley, T.S., Hawley, R.G., Dhoot, G.J. Current medical research and opinion. (2004) [Pubmed]
  26. Retrospective evaluation of commonly used equations to predict energy expenditure in mechanically ventilated, critically ill patients. Alexander, E., Susla, G.M., Burstein, A.H., Brown, D.T., Ognibene, F.P. Pharmacotherapy (2004) [Pubmed]
 
WikiGenes - Universities